Bhat A A, Pope J L, Smith J J, Ahmad R, Chen X, Washington M K, Beauchamp R D, Singh A B, Dhawan P
Department of Veterans Affairs, Tennessee Valley Healthcare System, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.
Oncogene. 2015 Aug 27;34(35):4570-80. doi: 10.1038/onc.2014.385. Epub 2014 Dec 15.
In normal colon, claudin-7 is one of the highly expressed claudin proteins and its knockdown in mice results in altered epithelial cell homeostasis and neonatal death. Notably, dysregulation of the epithelial homeostasis potentiates oncogenic transformation and growth. However, the role of claudin-7 in the regulation of colon tumorigenesis remains poorly understood. Using a large colorectal cancer (CRC) patient database and mouse models of colon cancer, we found claudin-7 expression to be significantly downregulated in cancer samples. Most notably, forced claudin-7 expression in poorly differentiated and highly metastatic SW620 colon cancer cells induced epithelial characteristics and inhibited their growth in soft agar and tumor growth in vivo. By contrast, knockdown of claudin-7 in HT-29 or DLD-1 cells induced epithelial-to-mesenchymal transition (EMT), colony formation, xenograft-tumor growth in athymic mice and invasion. Importantly, a claudin-7 signature gene profile generated by overlapping the DEGs (differentially expressed genes in a high-throughput transcriptome analysis using claudin-7-manipulated cells) with human claudin-7 signature genes identified high-risk CRC patients. Furthermore, Rab25, a colon cancer suppressor and regulator of the polarized cell trafficking constituted one of the highly upregulated DEGs in claudin-7 overexpressing cells. Notably, silencing of Rab25 expression counteracted the effects of claudin-7 expression and not only increased proliferation and cell invasion but also increased the expression of p-Src and mitogen-activated protein kinase-extracellular signal-regulated kinase 1/2 that were suppressed upon claudin-7 overexpression. Of interest, CRC cell lines, which exhibited decreased claudin-7 expression, also exhibited promoter DNA hypermethylation, a modification associated with transcriptional silencing. Taken together, our data demonstrate a previously undescribed role of claudin-7 as a colon cancer suppressor and suggest that loss of claudin-7 potentiates EMT to promote colon cancer, in a manner dependent on Rab25.
在正常结肠中,claudin-7是高表达的claudin蛋白之一,在小鼠中敲低该蛋白会导致上皮细胞稳态改变和新生小鼠死亡。值得注意的是,上皮稳态失调会增强致癌转化和生长。然而,claudin-7在结肠肿瘤发生调控中的作用仍知之甚少。利用一个大型结直肠癌(CRC)患者数据库和结肠癌小鼠模型,我们发现癌症样本中claudin-7的表达显著下调。最显著的是,在低分化和高转移性的SW620结肠癌细胞中强制表达claudin-7可诱导上皮特征,并抑制其在软琼脂中的生长以及体内肿瘤生长。相比之下,在HT-29或DLD-1细胞中敲低claudin-7会诱导上皮-间质转化(EMT)、集落形成、无胸腺小鼠体内异种移植瘤生长及侵袭。重要的是,通过将差异表达基因(使用claudin-7调控细胞进行高通量转录组分析中的差异表达基因)与人类claudin-7特征基因重叠生成的claudin-7特征基因谱可识别出高危CRC患者。此外,Rab25作为一种结肠癌抑制因子和极化细胞转运的调节因子,是claudin-7过表达细胞中上调程度最高的差异表达基因之一。值得注意的是,沉默Rab25表达可抵消claudin-7表达的作用,不仅增加增殖和细胞侵袭,还会增加p-Src和丝裂原活化蛋白激酶-细胞外信号调节激酶1/2的表达,而这两种蛋白在claudin-7过表达时会受到抑制。有趣的是,claudin-7表达降低的CRC细胞系也表现出启动子DNA高甲基化,这是一种与转录沉默相关的修饰。综上所述,我们的数据证明了claudin-7作为结肠癌抑制因子的一个此前未被描述的作用,并表明claudin-7的缺失以依赖Rab25的方式增强EMT以促进结肠癌。